Characterization of mice with cell type-specific Gnal loss of function provides insights on GNAL-linked dystonia
Isolated dystonia can be caused by loss-of-function mutations in the GNAL gene (DYT-GNAL/DYT25). This gene encodes the α<sub>olf</sub> subunit of the heterotrimeric G<sub>olf</sub> protein, which, with β<sub>2</sub>γ<sub>7</sub> subunits, mediates the stimulatory coupling of dopamine D1 and adenosine A2A receptors to adenylyl-cyclase. These receptors are expressed in distinct striatal projection neurons (SPNs) with complementary functions in motor behavior. To dissect the specific roles of Gα<sub>olf</sub> in the two main populations of SPNs, we generated and characterized mice in which Gnal was conditionally deleted in neurons expressing either D1 receptors (D1-SPNs) or A2A receptors (A2A-SPNs). Our results confirm the critical role of Gα<sub>olf</sub> in regulating adenylyl-cyclase 5 and its coupling with D1 and A2A receptors. Mice with a selective loss of Gα<sub>olf</sub> in D1-SPNs show nocturnal hyperactivity, deficits in motor performances, but no overt abnormal movements or generalized motor disability. Our experiments also reveal that Gα<sub>olf</sub> in D1-SPNs is required locomotor responses induced by some, but not all, D1 agonists or psychostimulants. Selective loss of Gα<sub>olf</sub> in A2A-SPNs does not affect motor abilities or learning but strikingly increases spontaneous locomotor activity. Hyperactivity is not further enhanced by psychostimulant drugs (cocaine, D-amphetamine, methylphenidate) or a selective A2 agonist, KW6002, but is paradoxically reduced by caffeine. Our study identifies specific roles of Gα<sub>olf</sub> downstream of D1 and A2A receptors in the control of motor behavior and drug responses, highlighting their respective individual contribution in dysfunctional striatal signaling, including dystonia.
Authors
- Denis Hervé (ORCID: https://orcid.org/0000-0003-1376-1522)
- Emmanuel Flamand Roze (ORCID: https://orcid.org/0000-0001-9727-3459)
- Sophie Longueville
- Jean‐Antoine Girault (ORCID: https://orcid.org/0000-0002-7900-1705)
- Assunta Pelosi (ORCID: https://orcid.org/0000-0002-6927-4494)
- Louise‐Laure Mariani (ORCID: https://orcid.org/0000-0002-2365-1223)
- Emmanuel Valjent (ORCID: https://orcid.org/0000-0002-1034-606X)
- Ruiyi Yuan
- Claire Naon (ORCID: https://orcid.org/0009-0004-6426-7721)
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université de Montpellier (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Institute for Neurosciences of Montpellier (FR)
- Institut du Fer à Moulin (FR)
- Institut du Cerveau (FR)
Publication Details
- Journal
- Neurobiology of Disease
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1016/j.nbd.2025.107071
- Citations
- 1
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39